Suppr超能文献

有或有心血管疾病风险的个人使用补充疗法:2007 年全国健康访谈调查结果。

Use of complementary therapies by individuals with or at risk for cardiovascular disease: results of the 2007 National Health Interview Survey.

机构信息

Center for the Study of Complementary and Alternative Therapies, School of Nursing, University of Virginia, Charlottesville, VA 22908-0782, USA.

出版信息

J Cardiovasc Nurs. 2012 Mar-Apr;27(2):96-102. doi: 10.1097/JCN.0b013e31821888cd.

Abstract

BACKGROUND

Complementary and alternative medicine (CAM) therapies are often used as adjuvants to conventional treatment by individuals with cardiovascular disease (CVD) or CVD risk factors, such as hypertension and high cholesterol. Patterns of use of CAM practices and products represent important data for health care providers in delivering adequate patient care.

OBJECTIVE

This study compared CAM use among the US CVD and general population, as well as individuals with CVD risk factors (hypertension and/or high cholesterol), through secondary analyses of the 2007 National Health Interview Survey data.

METHODS

The analysis compared use of CAM by individuals with CVD (those individuals self-reporting a diagnosis of coronary heart disease; n = 1055), individuals with CVD risk factors (those individuals self-reporting a diagnosis of hypertension [n = 6849] or high cholesterol [n = 5808]), and individuals who self-report as not having CVD or CVD risk factors (n = 22 290).

RESULTS

Use of complementary practices and products by patients with CVD and CVD risk factors is common and significantly greater than individuals without CVD in the general population. The most common categories of complementary modalities used by individuals with a self-reported diagnosis of CVD or CVD risk factors were natural products and mind-body practices.

CONCLUSIONS

The diagnosis of CVD or CVD risk factors may be associated with the use of complementary practices and products.

摘要

背景

患有心血管疾病(CVD)或 CVD 风险因素(如高血压和高胆固醇)的个体经常将补充和替代医学(CAM)疗法作为常规治疗的辅助手段。CAM 实践和产品的使用模式代表了医疗保健提供者为患者提供充分护理的重要数据。

目的

通过对 2007 年全国健康访谈调查数据的二次分析,本研究比较了美国 CVD 和一般人群以及 CVD 风险因素(高血压和/或高胆固醇)个体中 CAM 的使用情况。

方法

该分析比较了 CVD 患者(自我报告冠心病诊断的个体;n=1055)、CVD 风险因素患者(自我报告高血压诊断的个体[n=6849]或高胆固醇诊断的个体[n=5808])和自我报告无 CVD 或 CVD 风险因素的个体(n=22290)使用 CAM 的情况。

结果

患有 CVD 和 CVD 风险因素的患者使用补充性实践和产品很常见,且明显高于一般人群中无 CVD 的个体。自我报告患有 CVD 或 CVD 风险因素的个体最常使用的补充性治疗方法是天然产品和身心实践。

结论

CVD 或 CVD 风险因素的诊断可能与补充性实践和产品的使用有关。

相似文献

4
Use of complementary therapies in patients with cardiovascular disease.心血管疾病患者使用补充疗法的情况。
Am J Cardiol. 2006 Sep 1;98(5):673-80. doi: 10.1016/j.amjcard.2006.03.051. Epub 2006 Jul 7.

引用本文的文献

3
Systematic Review of Polyherbal Combinations Used in Metabolic Syndrome.代谢综合征中使用的多草药组合的系统评价
Front Pharmacol. 2021 Oct 7;12:752926. doi: 10.3389/fphar.2021.752926. eCollection 2021.

本文引用的文献

6
Integrative approaches for cardiovascular disease.心血管疾病的综合治疗方法。
Nutr Clin Pract. 2009 Dec;24(6):701-8. doi: 10.1177/0884533609343453.
7
Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension.辅酶Q10对原发性高血压的降压疗效。
Cochrane Database Syst Rev. 2009 Oct 7(4):CD007435. doi: 10.1002/14651858.CD007435.pub2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验